High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
Bowcock
Stella J
SJ
Rassam
Saad M B
SM
Lim
Ziyi
Z
Ward
Susan M
SM
Ryali
Madan M
MM
Mufti
Ghulam J
GJ
D000208:Acute Disease; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D019337:Hematologic Neoplasms / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine